abstract |
The present invention relates to novel 2-amino-3,4-dihydro-quinazoline derivatives, pharmaceutical compositions containing them and their use in the treatment of Alzheimer's disease (AD) and related disorders. The compounds of the present invention are inhibitors of β-secretase, also known as β-site cleaving enzyme and BACE. |